Detailed Narrative
Q1 Performance Overview
Molina Healthcare reported adjusted EPS of $2.35 on $10.2 billion of premium revenue for the first quarter, characterizing the results as solid. The consolidated MCR stood at 91.1%, indicating strong operating performance despite a challenging medical cost environment. The company achieved a 1.6% adjusted pretax margin in the quarter.
Medicaid Medical Cost Trend and Membership
The Medicaid segment reported a 92% MCR in Q1. Management noted that the January 1 rate updates were as expected, and the medical cost trend was modestly favorable. The 2.5% acuity shift observed in 2025 did not recur, and the annualized Q1 trend suggests it could be better than the 5% full-year assumption. Medicaid membership attrition is now expected to decline by 6% for FY26, up from a prior 2% guidance, primarily due to California, Illinois, New York, and Texas. However, management believes the acuity shift impact is largely behind them, as low and no utilizers are at their lowest levels.
Medicare Strategy and Performance
Medicare delivered an 89.8% MCR in Q1, in line with expectations. The company successfully transitioned MMP members to new integrated products (HIDE/FIDE), which are performing better than anticipated. Molina will exit the MAPD product for 2027, which is currently a $1.00 EPS drag. The strategic focus remains on the Duals business, with a positive outlook for 2027 due to an improved Stars profile.
Marketplace Segment Stability
The Marketplace segment achieved an 84% MCR in Q1, or approximately 79.5% when adjusted for prior year risk adjustment and program integrity impacts. Membership stands at 305,000, slightly higher than prior guidance. The segment benefits from a stable profile, with 70% renewal members concentrated in the silver tier, leading to greater predictability.
Prudent Guidance Reaffirmation
Despite strong first-quarter results, Molina reaffirmed its full-year 2026 adjusted EPS guidance of at least $5 and premium revenue of approximately $42 billion. Management emphasized this as a prudent approach given the early stage of the year and the need for more 'time-tested' results following the volatile medical cost environment of 2025. They plan to update guidance after Q2 results.
Florida CMS Contract Implementation
The Florida CMS Kids contract, with a total run rate of $6 billion, is in full implementation mode. Management views this program as financially attractive, expecting it to provide a meaningful addition to embedded earnings over a two-year period. The company is leveraging its expertise in managing high-acuity lives and behavioral costs for this contract.
M&A Pipeline and Capital Allocation
Molina indicated a 'replete' M&A pipeline with actionable opportunities, particularly for distressed Medicaid plans. The company remains disciplined in pursuing properties that fit its core strategy. Parent company cash is expected to exceed $600 million by year-end, with a debt-to-capital ratio of 47-48%, targeting the low 40s for a more sustainable level.